Literature DB >> 2773849

Evaluation of 24-second cyanide-containing and cyanide-free methods for whole blood hemoglobin on the Technicon H*1TM analyzer with normal and abnormal blood samples.

M J Malin1, L D Sclafani, J L Wyatt.   

Abstract

Automated methods, with and without cyanide (+CN and -CN), for whole blood hemoglobin (Hb) determination were evaluated on the Technicon H*1TM System. Both automated Hb methods were linear over the range 0-250 g/L (0-25 g/dL) and correlated well with the International Committee for Standardization of Hematology (ICSH) reference method and with the Coulter S+II. Both methods quantitatively converted whole blood containing up to 100% carboxyhemoglobin in less than 24 seconds to their respective end products. With respect to abnormal samples (sickle cell anemia, multiple myeloma, and hyperlipemia), both H*1 methods gave Hb results that were equivalent to the (postfiltration) ICSH method. For samples with white blood cell (WBC) counts less than 36 X 10(9)/L, the +CN method was equivalent to the (postfiltration) ICSH method, whereas for WBC counts greater than 20 X 10(9)/L, the -CN method showed acceptable recovery of the mean but unacceptable imprecision. For WBC counts of 36-164 X 10(9)/L, the +CN method yielded acceptable Hb recovery with unacceptable imprecision. Hyperlipemia, resulting from addition of Intralipid directly to the blood samples, caused large errors in both H*1 methods.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773849     DOI: 10.1093/ajcp/92.3.286

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  2 in total

1.  Two different hematocrit detection methods: different methods, different results?

Authors:  Marco Bosshart; John F Stover; Reto Stocker; Lars M Asmis; Jörg Feige; Thomas A Neff; Reto A Schuepbach; Silvia R Cottini; Markus Béchir
Journal:  BMC Res Notes       Date:  2010-03-09

2.  Hemodialysis-induced changes in hematocrit, hemoglobin and total protein: Implications for relative blood volume monitoring.

Authors:  Leszek Pstras; Malgorzata Debowska; Alicja Wojcik-Zaluska; Wojciech Zaluska; Jacek Waniewski
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.